New Medications

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Medication
Medication
FDA Approves First Treatment for Acid Sphingomyelinase Deficiency
09/20/2022
The FDA approved an intravenous infusion medication to treat symptoms of this rare genetic disease that affects the liver, spleen, lung, and brain.
09/20/2022
Treatment
Treatment
FDA Approves First Treatment for Active Psoriatic Arthritis in Pediatric Patients
08/23/2022
The US Food and Drug Administration has approved a new treatment for pediatric patients with active psoriatic arthritis.
08/23/2022
new medications
new medications
FDA Approved New Treatment for Heavy Menstrual Bleeding Caused by Uterine Fibroids
05/29/2020
The approval comes after results from 2 phase 3 trials showed that the medication significantly reduced the amount of heavy bleeding compared with placebo.
05/29/2020